Difference between revisions of "Example orders for mFOLFOX 6 in colon cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Just 10 days left" to "Just 9 days left") |
Warner-admin (talk | contribs) m (Text replacement - "Folinic acid (Leucovorin)" to "Leucovorin (Folinic acid)") |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | |
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 16: | Line 11: | ||
===Example regimen #1=== | ===Example regimen #1=== | ||
*[[Fluorouracil (5-FU)]] 400 mg/m<sup>2</sup> IV bolus over 10-15 minutes on day 1 after oxaliplatin and leucovorin | *[[Fluorouracil (5-FU)]] 400 mg/m<sup>2</sup> IV bolus over 10-15 minutes on day 1 after oxaliplatin and leucovorin | ||
| − | *[[Fluorouracil (5-FU)]] 1200 mg/ | + | *[[Fluorouracil (5-FU)]] 1200 mg/m<sup>2</sup>/day (total dose 2400 mg/m<sup>2</sup>) IV continuous infusion over 46 hours on days 1 to 2, given after 5-FU bolus |
| − | *[[Folinic acid | + | *[[Leucovorin (Folinic acid)]] 400 mg/m<sup>2</sup> IV over 2 hours on day 1, given first, concurrently with oxaliplatin |
**Mixed in 250 mL D5W. | **Mixed in 250 mL D5W. | ||
*[[Oxaliplatin (Eloxatin)]] 85 mg/m<sup>2</sup> IV over 2 hours on day 1, given first, concurrently with leucovorin | *[[Oxaliplatin (Eloxatin)]] 85 mg/m<sup>2</sup> IV over 2 hours on day 1, given first, concurrently with leucovorin | ||
| Line 24: | Line 19: | ||
'''14-day cycles x 12 cycles, to start within 10 weeks of surgery (if adjuvant); in metastatic settings, given until progression of disease or unacceptable toxicity''' | '''14-day cycles x 12 cycles, to start within 10 weeks of surgery (if adjuvant); in metastatic settings, given until progression of disease or unacceptable toxicity''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
*Ondansetron (Zofran) 8 mg IV 30 minutes prior to oxaliplatin | *Ondansetron (Zofran) 8 mg IV 30 minutes prior to oxaliplatin | ||
*[[Dexamethasone (Decadron)]] 10 mg IV 30 minutes prior to oxaliplatin | *[[Dexamethasone (Decadron)]] 10 mg IV 30 minutes prior to oxaliplatin | ||
| Line 33: | Line 28: | ||
Hydration: | Hydration: | ||
| − | *500 ml D5W at KVO rate as running IV for chemotherapy infusion. | + | *500 ml D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml D5W. |
Monitoring: | Monitoring: | ||
| − | *Hold if ANC | + | *Hold if ANC less than 1500 or platelets less than 75 and notify physician. |
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 15:40, 29 September 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
mFOLFOX 6
Published regimens and references may be found on the colon cancer page.
Example regimen #1
- Fluorouracil (5-FU) 400 mg/m2 IV bolus over 10-15 minutes on day 1 after oxaliplatin and leucovorin
- Fluorouracil (5-FU) 1200 mg/m2/day (total dose 2400 mg/m2) IV continuous infusion over 46 hours on days 1 to 2, given after 5-FU bolus
- Leucovorin (Folinic acid) 400 mg/m2 IV over 2 hours on day 1, given first, concurrently with oxaliplatin
- Mixed in 250 mL D5W.
- Oxaliplatin (Eloxatin) 85 mg/m2 IV over 2 hours on day 1, given first, concurrently with leucovorin
- Mixed in 500 mL D5W, and only infuse through D5W line.
14-day cycles x 12 cycles, to start within 10 weeks of surgery (if adjuvant); in metastatic settings, given until progression of disease or unacceptable toxicity
Supportive therapy
- Ondansetron (Zofran) 8 mg IV 30 minutes prior to oxaliplatin
- Dexamethasone (Decadron) 10 mg IV 30 minutes prior to oxaliplatin
- Lorazepam (Ativan) 0.5-1 mg PO prn nausea/anxiety, given 30 minutes prior to chemotherapy
Calcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start prior to oxaliplatin to decrease likelihood of neuropathyCalcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start after oxaliplatin infusion is complete to decrease likelihood of neuropathy- Calcium and magnesium no longer recommended to reduce risk of oxaliplatin-induced neuropathy: Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil, Louis Fehrenbacher, Philip J. Stella, Pamela J. Atherton, Drew K. Seisler, Rubina Qamar, Grant Carlton Lewis, Axel Grothey. Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An alliance for clinical trials in oncology study. 2013 ASCO Annual Meeting abstract 3501. link to abstract
Hydration:
- 500 ml D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml D5W.
Monitoring:
- Hold if ANC less than 1500 or platelets less than 75 and notify physician.